John Overdeck’s Terns Pharmaceuticals TERN Stock Holding History

John Overdeck’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-54,366	Closed	-$2.87M	–	5427
2026 Q1	$2.87M	Buy	54,366 +10,500	+24%	+$431K	﹤0.01%	2473
2025 Q4	$1.77M	Buy	43,866 +9,836	+29%	+$227K	﹤0.01%	2527
2025 Q3	$256K	Sell	34,030 -170,927	-83%	-$1.09M	﹤0.01%	3291
2025 Q2	$764K	Buy	204,957 +77,485	+61%	+$242K	﹤0.01%	2386
2025 Q1	$352K	Buy	127,472 +32,783	+35%	+$134K	﹤0.01%	2651
2024 Q4	$525K	Sell	94,689 -49,567	-34%	-$336K	﹤0.01%	2517
2024 Q3	$1.2M	Buy	144,256 +82,833	+135%	+$682K	﹤0.01%	2016
2024 Q2	$418K	Buy	+61,423	New	+$372K	﹤0.01%	2448

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

John Overdeck's TERN Position: Q2 2026 in Review

John Overdeck sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 54,366 shares — an estimated $2.87M sold.

John Overdeck first reported a position in TERN in Q2 2024 and held it in 8 quarters. The position peaked at $2.87M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

John Overdeck reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
John Overdeck sold 54,366 Terns Pharmaceuticals shares in Q2 2026, an estimated $2.87M.
John Overdeck first reported a position in Terns Pharmaceuticals in Q2 2024 and held it in 8 quarters.
John Overdeck's Terns Pharmaceuticals position peaked at $2.87M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.